This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Ingalill Avis: Innovator in Apelin Peptides
Introduction
Ingalill Avis is a notable inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of biotechnology, particularly in the area of apelin peptides. Her work focuses on the biological activity of these peptides and their potential applications in influencing cell growth.
Latest Patents
Ingalill Avis holds 1 patent for her invention titled "Apelin peptides and methods of use." This patent concerns the use of biologically active apelin peptides and compositions that are processed from larger precursor proteins. These peptides are further post-translationally modified to influence cell growth. The methods described in her patent are particularly useful for promoting or inhibiting cell growth, showcasing the versatility of apelin peptides in medical applications.
Career Highlights
Ingalill Avis is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her role at this prestigious institution allows her to engage in cutting-edge research and contribute to advancements in health and medicine.
Collaborations
In her career, Ingalill has collaborated with esteemed colleagues such as Frank Cuttitta and David Salomon. These collaborations have likely enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Ingalill Avis is a pioneering inventor whose work on apelin peptides has the potential to influence cell growth significantly. Her contributions to biotechnology are noteworthy, and her ongoing research at the National Institutes of Health continues to advance the field.